Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-27

Clinical Trial Update: Therapy Cool Path Ablate VT [NA]

View source ↗

Summary

Clinical trial update for Therapy Cool Path Ablate VT by Abbott Medical Devices; study on ischemic ventricular tachycardia was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Therapy Cool Path Ablate VT

Snippet

Sponsor: Abbott Medical Devices | Conditions: Ischemic Ventricular Tachycardia | NA | Status: TERMINATED | Results posted: 2016-05-27